These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 37497212)
1. Current understanding of CTLA-4: from mechanism to autoimmune diseases. Hossen MM; Ma Y; Yin Z; Xia Y; Du J; Huang JY; Huang JJ; Zou L; Ye Z; Huang Z Front Immunol; 2023; 14():1198365. PubMed ID: 37497212 [TBL] [Abstract][Full Text] [Related]
2. What did we learn from CTLA-4 insufficiency on the human immune system? Mitsuiki N; Schwab C; Grimbacher B Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239 [TBL] [Abstract][Full Text] [Related]
3. Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy. Kim GR; Choi JM Mol Cells; 2022 Aug; 45(8):513-521. PubMed ID: 35950451 [TBL] [Abstract][Full Text] [Related]
4. CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity. Chao G; Li X; Ji Y; Zhu Y; Li N; Zhang N; Feng Z; Niu M Biochem Biophys Res Commun; 2018 Nov; 505(3):865-871. PubMed ID: 30301533 [TBL] [Abstract][Full Text] [Related]
5. Female-biased incidence of experimental autoimmune encephalomyelitis reflects sexually dimorphic expression of surface CTLA-4 (CD152) on T lymphocytes. Luna RM; Körmendy D; Brunner-Weinzierl MC Gend Med; 2010 Aug; 7(4):296-308. PubMed ID: 20869630 [TBL] [Abstract][Full Text] [Related]
6. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886 [TBL] [Abstract][Full Text] [Related]
7. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Jain N; Nguyen H; Chambers C; Kang J Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1524-8. PubMed ID: 20080649 [TBL] [Abstract][Full Text] [Related]
9. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Wing K; Yamaguchi T; Sakaguchi S Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783 [TBL] [Abstract][Full Text] [Related]
10. Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report. Kolcava J; Litzman J; Bednarik J; Stulik J; Stourac P Mult Scler Relat Disord; 2020 Oct; 45():102313. PubMed ID: 32623363 [TBL] [Abstract][Full Text] [Related]
11. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575 [TBL] [Abstract][Full Text] [Related]
12. CTLA-4: From mechanism to autoimmune therapy. Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707 [TBL] [Abstract][Full Text] [Related]
13. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. Schmidt EM; Wang CJ; Ryan GA; Clough LE; Qureshi OS; Goodall M; Abbas AK; Sharpe AH; Sansom DM; Walker LS J Immunol; 2009 Jan; 182(1):274-82. PubMed ID: 19109158 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4. Yang M; Klocke K; Hernandez CM; Xu B; Gjertsson I; Wing K; Holmdahl R Immunology; 2018 Dec; 155(4):446-457. PubMed ID: 29992549 [TBL] [Abstract][Full Text] [Related]
15. CTLA-4: a key regulatory point in the control of autoimmune disease. Scalapino KJ; Daikh DI Immunol Rev; 2008 Jun; 223():143-55. PubMed ID: 18613834 [TBL] [Abstract][Full Text] [Related]